The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 13, 2015, Pages E1550-E1558

  Jones, Matthew F ^a,b   Hara, Toshifumi ^b   Francis, Princy ^b   Li, Xiao Ling ^b   Bilke, Sven ^b   Zhu, Yuelin ^b   Pineda, Marbin ^b   Subramanian, Murugan ^b   Bodmer, Walter F ^a   Lal, Ashish ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; CDX1; Colorectal cancer; MiR 215; MiRNA

Indexed keywords

MICRORNA; MICRORNA 215; RNA INDUCED SILENCING COMPLEX; TRANSCRIPTION FACTOR CDX1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONTROL; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HCT116 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LUCIFERASE ASSAY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; RNA SEQUENCE; STABLE TRANSFECTION; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING;

EID: 84975094028     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1503370112     Document Type: Article

References (48)

1. Chan CWM, et al. (2009) Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci USA 106(6):1936-1941.
2. Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 107(8):3722-3727.
3. Ashley N, Yeung TM, Bodmer WF (2013) Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. Cancer Res 73(18):5798-5809.
4. Wong NA, et al. (2004) Loss of CDX1 expression in colorectal carcinoma: Promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci USA 101(2):574-579.
5. Pilozzi E, Onelli MR, Ziparo V, Mercantini P, Ruco L (2004) CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation. J Pathol 204(3):289-295.
6. Yeung TM, Gandhi SC, Bodmer WF (2011) Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108(11):4382-4387.
7. Yan KS, et al. (2012) The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci USA 109(2):466-471.
8. Tian H, et al. (2011) A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478(7368):255-259.
9. Arango D, et al. (2012) Villin expression is frequently lost in poorly differentiated colon cancer. Am J Pathol 180(4):1509-1521.
10. Staloch LJ, Divine JK, Witten JT, Simon TC (2005) C/EBP and Cdx family factors regulate liver fatty acid binding protein transgene expression in the small intestinal epithelium. Biochim Biophys Acta 1731(3):168-178.
11. Mutoh H, et al. (2004) Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: Comparative study with Cdx2 transgenic mice. Gut 53(10):1416-1423.
12. Fujii Y, et al. (2012) CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc Natl Acad Sci USA 109(50):20584-20589.
13. Wong NA, et al. (2005) CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci USA 102(21):7565-7570.
14. Hermeking H (2012) MicroRNAs in the p53 network: Micromanagement of tumour suppression. Nat Rev Cancer 12(9):613-626.
15. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126-139.
16. Lu J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834-838.
17. Dvinge H, et al. (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497(7449):378-382.
18. Kumar MS, et al. (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23(23):2700-2704.
19. Calin GA, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999-3004.
20. Jones M, Lal A (2012) MicroRNAs, wild-type and mutant p53: More questions than answers. RNA Biol 9(6):781-791.
21. Subramanian M, et al. (2014) A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis. Oncogene.
22. Okada N, et al. (2014) A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 28(5):438-450.
23. Chang T-C, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5):745-752.
24. Masciarelli S, et al. (2014) Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. Oncogene 33(12):1601-1608.
25. Ameres SL, Zamore PD (2013) Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 14(8):475-488.
26. Creighton CJ, Reid JG, Gunaratne PH (2009) Expression profiling of microRNAs by deep sequencing. Brief Bioinform 10(5):490-497.
27. Schug J (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics Chapter 2:Unit 2.6.
28. He L, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828-833.
29. Braun CJ, et al. (2008) p53-responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68(24):10094-10104.
30. Georges SA, et al. (2008) Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 68(24):10105-10112.
31. Pichiorri F, et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18(4):367-381.
32. Thomson DW, Bracken CP, Szubert JM, Goodall GJ (2013) On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS ONE 8(1):e55214.
33. Li XL, et al. (2014) A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 34(3):533-550.
34. Kluiver J, et al. (2012) Rapid generation of microRNA sponges for microRNA inhibition. PLoS ONE 7(1):e29275.
35. Ghandi S (2010) Regulation of stemness and differentiation in colorectal cancer. PhD dissertation (University of Oxford, Oxford, UK). Available at ora.ox.ac.uk/objects/uuid: a32fd55a-4b1e-4a15-9f79-9fdbd986774a.
36. Sangiorgi E, Capecchi MR (2008) Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40(7):915-920.
37. Ashley N, Jones M, Ouaret D, Wilding J, Bodmer WF (2014) Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays. J Pathol 234(1):34-45.
38. Gautier-Stein A, et al. (2003) Differential regulation of the glucose-6-phosphatase TATA box by intestine-specific homeodomain proteins CDX1 and CDX2. Nucleic Acids Res 31(18):5238-5246.
39. Wijnhoven BPL, et al.; South Australian Oesophageal Research Group (2010) MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 97(6): 853-861.
40. Lavery DL, et al. (2014) The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands. Gut 63(12):1854-1863.
41. Cheung TH, et al. (2012) Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482(7386):524-528.
42. Bu P, et al. (2013) A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 12(5):602-615.
43. Kreso A, et al. (2014) Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 20(1):29-36.
44. Kasinski AL, Slack FJ (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11(12):849-864.
45. Broderick JA, Zamore PD (2011) MicroRNA therapeutics. Gene Ther 18(12):1104-1110.
46. Lal A, et al. (2011) Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PloS Genet 7(11):e1002363.
47. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
48. Mootha VK, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3): 267-273.